Exploring the Cognitive Benefits of Dihexa in Neurodegenerative Disease Models
As the prevalence of neurodegenerative diseases continues to rise globally, the search for innovative therapeutic interventions has become increasingly urgent. Among the emerging candidates, Dihexa has garnered significant attention for its unique neurotrophic properties and cognitive-enhancing effects. Developed from angiotensin IV analogs, Dihexa exhibits the remarkable ability to promote synaptogenesis—positioning it as a potential game-changer […]